Company / Debt per Share
AVADEL PHARMACEUTICALS PLC Debt per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.52
FY2022
5-year range
$1.52 / $2.43
FY2018-FY2022
Trend
-37.3%
vs FY2021
Sector context
#49 of 82
Health Care
What the data says
At $1.52, AVADEL PHARMACEUTICALS PLC's debt per share ranks #34 of 82 in the Health Care sector. Debt per Share has fluctuated over the past 8 years, ranging from $0.01 in FY2017 to $3.25 in FY2019.
Based on SEC 10-K filings.
1.52 in FY2022 with a 5-year CAGR of +198.9%.
Improved from $2.33 to $1.52 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -22.3%
- 5-Year CAGR
- +198.9%
- 10-Year CAGR
- -
Sector benchmark
#34 of 82 in Health CareTop 40% of 82This company $1.52 Sector average $151.59
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2022, debt per share decreased 37.3% year-over-year.
- Ranks #49 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2019.
- Lowest debt per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $1.52 | -37.3% |
| FY2021 | $2.43 | +4.2% |
| FY2020 | $2.33 | -28.3% |
| FY2019 | $3.25 | +4.8% |
| FY2018 | $3.10 | +48446.7% |
| FY2017 | $0.01 | -51.8% |
| FY2016 | $0.01 | -15.4% |
| FY2015 | $0.02 | -55.5% |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026